Clinical Trial Results: Positive data boosts investor confidence, driving up the stock. Negative results can cause a significant price decline.

Regulatory Decisions: FDA approval or rejection of Madrigal's drugs directly influences stock value. Approval leads to increased revenue potential.

Competition: Development of competing drugs for NASH can negatively impact MDGL's market share expectations and price.

Market Conditions: Overall market sentiment (bullish or bearish) affects all stocks. A downturn can pull MDGL down even with good news.

Company Financials: Revenue, earnings, and cash flow provide insight into the company's health. Strong financials can attract investors.

Analyst Ratings: Positive ratings and price targets from analysts can encourage buying, while negative ones can lead to selling.

Investor Sentiment: Public opinion and media coverage influence stock demand. Positive press can attract more investors.

Partnerships and Acquisitions: Collaborations or being acquired can significantly impact the stock price, depending on the deal's terms.